These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 17609821

  • 1. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A, Lim YS, Zulkifli SZ, Zarina AL, Nordiah AJ, Jamal R.
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [Abstract] [Full Text] [Related]

  • 2. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A, Rizal AM, Nordiah AJ, Jamal R.
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [Abstract] [Full Text] [Related]

  • 3. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 4. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
    Düzova A, Kutluk T, Kanra G, Büyükpamukçu M, Akyüz C, Seçmeer G, Ceyhan M.
    Turk J Pediatr; 2001 Mar; 43(2):105-9. PubMed ID: 11432485
    [Abstract] [Full Text] [Related]

  • 5. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [Abstract] [Full Text] [Related]

  • 6. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H, Ai CL, Lee CL, Abdullah WA.
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R, Görgün O, Ayan I, Gürler N, Akici F, Töreci K.
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [Abstract] [Full Text] [Related]

  • 8. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Marie-Cardine A, Schneider P, Blot N, Tron P, Vannier JP.
    Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
    [Abstract] [Full Text] [Related]

  • 9. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
    Kwon KT, Cheong HS, Rhee JY, Wi YM, Ryu SY, Heo ST, Moon CS, Ki HK, Kim KH, Jung CW, Peck KR, Song JH.
    Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
    [Abstract] [Full Text] [Related]

  • 10. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R, Blaise D, Espinouse D, Leblond V, Sadoun A, Sauvage C, Cordonnier C, Minozzi C.
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [Abstract] [Full Text] [Related]

  • 11. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV.
    Cancer; 2003 Sep 01; 98(5):1039-47. PubMed ID: 12942573
    [Abstract] [Full Text] [Related]

  • 12. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A, Karadeniz C, Citak EC, Cil V, Eldes N.
    Pediatr Hematol Oncol; 2006 Sep 01; 23(3):245-53. PubMed ID: 16517540
    [Abstract] [Full Text] [Related]

  • 13. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
    de la Cámara R, Figuera A, Sureda A, Hermida G, Verge G, Olalla I, Fernández Rañada JM, Domingo Albos A.
    Haematologica; 1997 Sep 01; 82(6):668-75. PubMed ID: 9580087
    [Abstract] [Full Text] [Related]

  • 14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 01; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, Eryilmaz E, Goksan B, Unuvar A, Agirbasli H, Can M, Bilgen H, Gedikoglu G.
    J Chemother; 2001 Jun 01; 13(3):281-7. PubMed ID: 11450887
    [Abstract] [Full Text] [Related]

  • 16. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH, Nasim S, Ahmed A, Irfan M, Ishaque A, Farzana T, Panjwani VK, Taj M, Shamsi TS.
    J Coll Physicians Surg Pak; 2006 Nov 01; 16(11):704-8. PubMed ID: 17052420
    [Abstract] [Full Text] [Related]

  • 17. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I, Spanish PETHEMA Group.
    J Antimicrob Chemother; 2002 Jul 01; 50(1):79-88. PubMed ID: 12096010
    [Abstract] [Full Text] [Related]

  • 18. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H, Björkholm M, Engervall P, Johansson P, Ljungman P, Hast R, Kalin M.
    Scand J Infect Dis; 2004 Jul 01; 36(8):593-600. PubMed ID: 15370671
    [Abstract] [Full Text] [Related]

  • 19. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec 01; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 20. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J, Segura A, Bosch C, Galan A, Juan O, Molins C, Giner V, Aparicio J.
    Med Oncol; 2002 Dec 01; 19(3):161-6. PubMed ID: 12482126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.